(Q35787503)

10 August 2017

1 reference

title

Alterations of common chromosome fragile sites in hematopoietic malignancies (English)

1 reference

10 August 2017

Hideshi Ishii

1

1 reference

10 August 2017

Yusuke Furukawa

series ordinal

2

1 reference

10 August 2017

publication date

1 April 2004

1 reference

International Journal of Hematology

10 August 2017

published in

1 reference

10 August 2017

volume

79

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

238-242

1 reference

https://scigraph.springernature.com/pub.10.1532/ijh97.03145

10 August 2017

exact match

0 references

cites work

Tumor suppressor genes in normal and malignant hematopoiesis

1 reference

12 December 2020

WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer

1 reference

12 December 2020

DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes

1 reference

12 December 2020

Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding

1 reference

12 December 2020

WWOX: a candidate tumor suppressor gene involved in multiple tumor types

1 reference

12 December 2020

WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Constitutive fragile sites and cancer.

1 reference

12 December 2020

Multiple molecular alterations of FHIT in betel-associated oral carcinoma

1 reference

12 December 2020

Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma

1 reference

12 December 2020

Common fragile sites.

1 reference

12 December 2020

Altered methylation patterns in cancer cell genomes: cause or consequence?

1 reference

12 December 2020

Aberrant expression and deletion of FHIT gene in leukemias

1 reference

12 December 2020

Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma

1 reference

12 December 2020

Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia

1 reference

12 December 2020

Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features

1 reference

12 December 2020

Gene therapy of hepatocellular carcinoma

1 reference

12 December 2020

ATR Regulates Fragile Site Stability

1 reference

12 December 2020

Compilation of published comparative genomic hybridization studies

1 reference

12 December 2020

Frequent aberration of FHIT gene expression in acute leukemias.

1 reference

12 December 2020

JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis

1 reference

12 December 2020

Fragile and unstable chromosomes in cancer: causes and consequences

1 reference

12 December 2020

Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas

1 reference

12 December 2020

Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression

1 reference

12 December 2020

Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies

1 reference

12 December 2020

Tumour suppressor genes in sporadic epithelial ovarian cancer

1 reference

12 December 2020

Hereditary Renal-Cell Carcinoma Associated with a Chromosomal Translocation

1 reference

12 December 2020

FHIT expression and hypermethylation in esophageal squamous cell carcinoma

1 reference

12 December 2020

5'-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas

1 reference

12 December 2020

Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies

1 reference

12 December 2020

Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells

1 reference

12 December 2020

WWOX, the common chromosomal fragile site, FRA16D, cancer gene

1 reference

12 December 2020

The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer

1 reference

12 December 2020

Significance of FHIT expression in chronic myelogenous leukemia

1 reference

12 December 2020

Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer

1 reference

12 December 2020

The role of PML in tumor suppression

1 reference

12 December 2020

Aberrant FHIT transcripts in acute myeloid leukaemia.

1 reference

12 December 2020

WWOX, the FRA16D gene, behaves as a suppressor of tumor growth

1 reference

12 December 2020

Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion

1 reference

12 December 2020

Role of TCL1 and ALL1 in human leukemias and development

1 reference

12 December 2020

Chromosomes in lymphomas and solid tumors

1 reference

12 December 2020

5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer

1 reference

12 December 2020

Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia

1 reference

12 December 2020

The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control

1 reference

12 December 2020

FRA3B and other common fragile sites: the weakest links

1 reference

12 December 2020

Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors

1 reference

12 December 2020

Cancer-specific chromosome alterations in the constitutive fragile region FRA3B.

1 reference

12 December 2020

Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer

1 reference

12 December 2020

Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells

1 reference

12 December 2020

Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features

1 reference

12 December 2020

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

1 reference

12 December 2020

Replacement of Fhit in cancer cells suppresses tumorigenicity

1 reference

12 December 2020

Chronic myelogenous leukemia

1 reference

12 December 2020

Loss of FHIT expression in acute lymphoblastic leukemia

1 reference

12 December 2020

Self-fusion of the ALL1 gene. A new genetic mechanism for acute leukemia

1 reference

12 December 2020

Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies

1 reference

12 December 2020

Identifiers

DOI

10.1532/IJH97.03145

1 reference

Dimensions Publication ID

10 August 2017

1022193984

0 references

1 reference